CTEV
Overvalued by 176.2% based on the discounted cash flow analysis.
Market cap | $374.98 Million |
---|---|
Enterprise Value | $4.89 Billion |
Dividend Yield | $NaN (NaN%) |
Earnings per Share | $- |
Beta | - |
Outstanding Shares | - |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | - |
---|---|
PEG | - |
Price to Sales | - |
Price to Book Ratio | - |
Enterprise Value to Revenue | 5.22 |
Enterprise Value to EBIT | -11.73 |
Enterprise Value to Net Income | -8 |
Total Debt to Enterprise | 0.93 |
Debt to Equity | -114.5 |
No data
No data
Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-...